BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20558109)

  • 1. Minor diurnal and activity-induced variations in daytime peripheral blood platelet counts do not have any major impact on platelet yield by platelet apheresis.
    Akkök CA; Hervig T; Bjørsvik S; Underdal MO; Skoug CF; Ersvaer E; Bruserud Ø
    Transfus Apher Sci; 2010 Aug; 43(1):33-6. PubMed ID: 20558109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL.
    Alex J; Roberts B; Raife T
    J Clin Apher; 2009; 24(5):215-7. PubMed ID: 19816960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Impact-R for monitoring the platelet storage lesion.
    Albanyan AM; Murphy MF; Harrison P
    Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
    Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
    Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.
    Katz L; Palmer K; McDonnell E; Kabat A
    Transfusion; 2007 Sep; 47(9):1601-6. PubMed ID: 17725723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
    Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony-stimulating factor increases the platelet volume in peripheral stem cell apheresis donors.
    Ihara A; Matsui K; Minami R; Uchida S; Ueda S; Nishiura T
    Pathophysiol Haemost Thromb; 2008; 36(5):266-70. PubMed ID: 19996637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
    Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
    Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of platelet parameters in healthy apheresis donors using the ADVIA 120.
    Ifran A; Haşimi A; Kaptan K; Nevruz O; Beyan C; Erbil K
    Transfus Apher Sci; 2005 Oct; 33(2):87-90. PubMed ID: 16139569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
    Procházková R; Andrýs C; Hubácková L; Krejsek J
    Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tobacco smoking on platelet function in apheresis products in vitro.
    Scheinichen D; Heuft HG; Renken C; Jüttner B; Jaeger K; Schürholz T; Blasczyk R; Piepenbrock S; Elsner HA
    Vox Sang; 2004 May; 86(4):252-6. PubMed ID: 15144530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequently used plateletpheresis techniques result in variable target yields and platelet recruitment of donors.
    Strasser EF; Schuster M; Egler K; Bauer J; Weisbach V; Ringwald J; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2005 May; 45(5):788-97. PubMed ID: 15847670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and safety of triple dose platelet collection by apheresis.
    Moog R
    J Clin Apher; 2009; 24(6):238-40. PubMed ID: 19908304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles.
    Rank A; Nieuwland R; Liebhardt S; Iberer M; Grützner S; Toth B; Pihusch R
    Vox Sang; 2011 Feb; 100(2):179-86. PubMed ID: 20701731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of high-yield thrombocytapheresis on the quality of platelet products.
    Julmy F; Ammann RA; Mansouri Taleghani B; Fontana S; Hirt A; Leibundgut K
    Transfusion; 2008 Mar; 48(3):442-50. PubMed ID: 18067508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
    Pietersz RN
    Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis.
    Stohlawetz P; Stiegler G; Jilma B; Dettke M; Höcker P; Panzer S
    Transfusion; 1998 May; 38(5):454-8. PubMed ID: 9633558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apheresis donors and platelet function: inherent platelet responsiveness influences platelet quality.
    Garner SF; Jones CI; Stephens J; Burns P; Walton J; Bernard A; Angenent W; Ouwehand WH; Goodall AH;
    Transfusion; 2008 Apr; 48(4):673-80. PubMed ID: 18194381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic, laboratory, and operational variables that influence short- and long-term plateletpheresis yields.
    Badami KG; Sesun M; Basu A; Absalom N
    J Clin Apher; 2012 Nov; 27(5):247-54. PubMed ID: 22730096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.